European Surveillance of Legionnaires' Disease

Legionnaires ’ disease • The European community strategy against antimicrobial resistance

" Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information " Leg i on n ai res ' di sease • The European community strategy against antimicrobial resistance • Legionnaires' disease clusters associated Peer-reviewed European information on communicable disease surveillance and control O u t b r e...

A Case Report of Severe Legionnaires’ Disease in Tehran, Iran

Legionella pneumophila is a thin, aerobic, Gram-negative, pathogenic bacillus and the leading cause of Legionnaires’ disease (LD) in human, especially those with high risk conditions including immune system disorders or chronic lung diseases. The mortality rate of LD has been reported to be 60% or higher in inappropriately treated cases. Investigating the prevalence of L. pneumophila and identi...

Monochloramine and Legionnaires' disease

egionnaires’ disease was first recognized in 1976 during an outbreak among attendees at an American Legion convention. The disease is a form of pneumonia caused by bacteria of the genus Legionella. Legionella thrives at warm temperatures (25–42oC [77–108oF]). It lives inside biofilm in aquatic environments, usually as an intracellular parasite of amoebae.1 This lifestyle protects it from disinf...

What is Legionnaires' Disease?

Epidemiological investigation of a case of nosocomial Legionnaires' disease in Taiwan: implications for routine environmental surveillance.

An epidemiological investigation with Legionella and molecular subtyping was conducted to determine the source of a case of nosocomial Legionnaires' disease (LD) who was hospitalized in three hospitals within a month. Legionella pneumophila serogroup 3, an uncommon serogroup for infection, was isolated from the patient's sputum. Environmental surveillance revealed Legionella colonization in all...